Press Releases

Dr. Massimo Loda Appointed Chair of the Department of Pathology and Laboratory Medicine at Weill Cornell Medicine and Pathologist-in-Chief at NewYork-Presbyterian/Weill Cornell Medical Center

Dr. Lisa Newman, an internationally renowned breast surgeon and researcher, has been appointed chief of the Section of Breast Surgery at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine, effective Aug. 20. 

NEW YORK (July 30, 2018)—Dr. Laura Riley, a renowned obstetrician who specializes in obstetric...

Dr. Francis Lee, a leading physician-scientist whose research focuses on anxiety disorders, has been named chairman of the Department of Psychiatry at Weill Cornell Medicine and psychiatrist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1.

A very low carbohydrate, high-fat diet called the ketogenic diet may improve the effectiveness of an emerging class of cancer drugs, according to a study in mice by investigators at Weill Cornell Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian.

Dr. Peter T. Meinke, an accomplished chemist with more than 30 years of industry and academic experience, has been selected to lead the Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI).

Recognizing the increasing importance of emergency medicine as an academic discipline, Weill Cornell Medicine has expanded the Division of Emergency Medicine into a comprehensive department effective July 1. 

NewYork-Presbyterian, in collaboration with Weill Cornell Medicine, Columbia University Irving Medical Center and the Fire Department of New York (FDNY), is expanding its fleet of Mobile Stroke Treatment Units (MSTU) to Queens and Brooklyn. 

On May 6, the National Institutes of Health will open national enrollment for the All of Us Research Program—a momentous effort to advance individualized prevention, treatment and care for people of all backgrounds. A consortium that includes Columbia University Irving Medical Center, Weill Cornell Medicine, NYC Health + Hospitals/Harlem and NewYork-Presbyterian is spearheading enrollment in New York City. 

Dr. Vijay Sankaran, a physician-scientist who investigates the molecular underpinnings of pediatric genetic blood disorders, has been awarded the third annual Gale and Ira Drukier Prize in Children’s Health Research, Weill Cornell Medicine announced today.

To expand access to life-saving liver transplants for those in need, NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine have unveiled a new living donor liver transplant program. It performed its first such transplant with success in late January.

Mark Veich, an accomplished leader in institutional advancement, has been appointed vice provost for external affairs at Weill Cornell Medicine, effective Feb. 12.

Dr. Said Ibrahim, a leading physician-scientist whose research focuses on healthcare disparities, has been named the inaugural chief of the newly established Division of Healthcare Delivery Science and Innovation in the Department of Healthcare Policy and Research at Weill Cornell Medicine, effective Feb. 1.

Dr. Anthony Hollenberg, a leading physician-scientist specializing in endocrinology, has been appointed chairman of the Joan and Sanford I. Weill Department of Medicine at Weill Cornell Medicine and physician-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, effective Feb. 1.

Weill Cornell Medicine has received a $45.3 million renewal grant from the National Institutes of Health’s Clinical and Translational Science Awards Program to continue funding its multi-institutional Clinical and Translational Science Center until 2022.

Internationally renowned neuro-oncologist Dr. Howard A. Fine of Weill Cornell Medicine and NewYork-Presbyterian will receive a five-year, $6 million National Institutes of Health Director’s Pioneer Award for brain cancer research.

A new study finds that it isn’t just the amount of time spent sitting, but also the way in which sitting time is accumulated during the day, that can affect risk of early death.

Weill Cornell Medicine has been awarded a five-year, $11.3 million Specialized Programs of Research Excellence grant from the National Cancer Institute to improve the detection, diagnosis and treatment of prostate cancer. 

ARCADIA, a multicenter phase III trial, will study the role of abnormalities in the structure and function of the heart’s left atrium, or atrial cardiopathy, in stroke patients, and test a medication that could prevent them from experiencing recurrent strokes.

NewYork-Presbyterian/Weill Cornell Medical Center has been verified as a Level I Adult and a Level II Pediatric Trauma Center by the American College of Surgeons’ Committee on Trauma.